⬇ Novo Nordisk - When I wrote my piece on Novo Nordisk yesterday, I was not expecting their Annual Report to be released the same day along with a 2026 guidance that sent the shares sharply down 14% in a single day.

Continue reading on Smartkarma:- https://www.smartkarma.com/insights/re-recontextualising-novo-nordisk-not-so-cheap-anymore?utm_source=tiger_community

By Unfair Advantage, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/unfair-advantage?utm_source=tiger_community

On Novo Nordisk (NVO):- https://www.smartkarma.com/entities/novo-nordisk-a-s-ba872722-aea4-4193-b627-b24b9ec09595?utm_source=tiger_community

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.